LUP Statistics
Record
- Title
- Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases
- Type
- Journal Article
- Publ. year
- 2010
- Author/s
- Martini, Paolo G. V.; Cook, Lynette C.; Alderucci, Scott; Norton, Angela W. et al.
- Department/s
- Division of Microbiology, Immunology and Glycobiology - MIG; Rheumatology
- In LUP since
- 2016-04-01
Downloads
Total | This Year | This Month |
356 | 8 | 2 |
United States of America | 234 (66%) |
Czechia | 24 (7%) |
Germany | 22 (6%) |
China | 18 (5%) |
Russian Federation | 15 (4%) |
Sweden | 13 (4%) |
United Kingdom of Great Britain and Northern Ireland | 5 (1%) |
Ukraine | 4 (1%) |
France | 3 (1%) |
Ireland | 2 (1%) |
Hong Kong (China) | 2 (1%) |
South Africa | 2 (1%) |
India | 1 (0%) |
Yemen | 1 (0%) |
European Union location | 1 (0%) |
South Korea | 1 (0%) |
Australia | 1 (0%) |
Denmark | 1 (0%) |
Netherlands | 1 (0%) |
Turkey | 1 (0%) |
Hungary | 1 (0%) |
Iran | 1 (0%) |
Spain | 1 (0%) |
United Arab Emirates | 1 (0%) |